Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

TOWARD 3D HUMAN BRAIN-LIKE TISSUES FOR TARGETING DYSREGULATED SYNAPSE AND PROTEOSTASIS MECHANISMS IN ALZHEIMER'S DISEASE

Award Number: R03AG067970
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/30/2020
PERIOD OF PERFORMANCE END DATE: 06/30/2024

Group Awards By:

View Award Description

TOWARD 3D HUMAN BRAIN-LIKE TISSUES FOR TARGETING DYSREGULATED SYNAPSE AND PROTEOSTASIS MECHANISMS IN ALZHEIMER'S DISEASE - ABSTRACT. Alzheimer’s disease (AD) is a neurodegenerative disorder affecting 5.8 million people in the US alone with an estimated $290 billion in annual costs. The disease is characterized by significant memory loss and behavioral abnormalities that are often devastating to quality of life. Memory and behavior are directly related to the underlying changes of the central nervous system (CNS) brain tissue. While many types of CNS abnormalities are differentially reported in AD studies, dysregulated synapse maintenance is consistently found to be altered across AD model systems. Mechanistically, synapse alterations have been shown to converge on many pathways related to proteostasis – including mTOR, macroautophagy, and ubiquitin-proteasome system (UPS) pathways – suggesting a potential unifying approach for treating AD. To date, no effective therapy targeting these pathways exists, owing in part to our nascent understanding of the interplay between these processes in the AD brain. Thus, there is a need to deepen our understanding of these mechanisms as well as to develop novel approaches to target them. Traditionally, mechanistic knowledge of AD has been gained with in vivo animal models and with analyses of post-mortem human brains. However, current animal models of AD are not fully representative of the human condition, and analyses in human brains suffer from a lack of supply, throughput, and experimental control. Induced pluripotent stem cells (iPSCs) have enabled access to live human neurons, but associated studies have largely been performed on 2D plastic surfaces. We propose a 3D material- based approach to enable the study of dysregulated synapse maintenance and proteostasis mechanisms of AD in humans. Compared to alternative 3D models, such as organoids, our tissue engineering approach provides for a highly reproducible, custom design of biophysical and biochemical cell-ECM interactions. Our proposed entry point into these questions is with iPSCs derived from patients with mutant presenilin-1 (PSEN1), one of the most well characterized familial mutations causative of AD. Our 3D models will incorporate human ADPSEN1 iPSC-derived neurons (iNeurons) to mimic key cell-cell interactions known to be important in synapse maintenance. Upon successful completion of the proposed aims, we will have developed 3D human brain-like tissues allowing for more in depth analysis of mechanisms linking dysregulated synapses and network activity with proteostasis pathways. These models can be utilized as additional tools in the drug discovery and validation pipeline, offering unique relevance compared to other in vitro human and in vivo mouse model systems.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2021	RENSSELAER POLYTECHNIC INSTITUTE	110 8TH ST	TROY	NY	12180	RENSSELAER	USA	Aging Research	000	2	11/5/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	RENSSELAER POLYTECHNIC INSTITUTE	110 8TH ST	TROY	NY	12180	RENSSELAER	USA	Aging Research	000	2	5/19/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $81,000 )
2021	2021	RENSSELAER POLYTECHNIC INSTITUTE	110 8TH ST	TROY	NY	12180	RENSSELAER	USA	Aging Research	000	2	6/30/2021	NON-COMPETING CONTINUATION	$81,000
2021	2020	RENSSELAER POLYTECHNIC INSTITUTE	110 8TH ST	TROY	NY	12180	RENSSELAER	USA	Aging Research	001	1	7/16/2021	NEW	$0
														Subtotal = $81,000

Issue Date FY: 2020 ( Subtotal = $81,000 )
2020	2020	RENSSELAER POLYTECHNIC INSTITUTE	110 8TH ST	TROY	NY	12180	RENSSELAER	USA	Aging Research	000	1	9/15/2020	NEW	$81,000
														Subtotal = $81,000

Grand Total All Awards = $162,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

TOWARD 3D HUMAN BRAIN-LIKE TISSUES FOR TARGETING DYSREGULATED SYNAPSE AND PROTEOSTASIS MECHANISMS IN ALZHEIMER'S DISEASE

Award Number: R03AG067970

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/30/2020

PERIOD OF PERFORMANCE END DATE: 06/30/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer